BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27136491)

  • 1. Significantly prolonged neuromuscular blockade after a single dose of rocuronium: The importance of monitoring.
    Soares M; Esteves S
    Eur J Anaesthesiol; 2016 Sep; 33(9):693-4. PubMed ID: 27136491
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
    Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
    Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged residual paralysis after a single intubating dose of rocuronium: an unexpected cause].
    Guerci P; Vial F; Raft J; Meistelman C; Bouaziz H
    Ann Fr Anesth Reanim; 2012; 31(7-8):632-4. PubMed ID: 22763308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extremely prolonged neuromuscular blockade after rocuronium: a case report.
    Morales Martín AC; Vaquero Roncero LM; Muriel Villoria C
    Acta Anaesthesiol Scand; 2009 Aug; 53(7):957-9. PubMed ID: 19397500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged neuromuscular blockade associated with rocuronium.
    Lewis KS; Santucci VN; Normoyle DL; Rothenberg DM
    Am J Health Syst Pharm; 1999 Jun; 56(11):1114-8. PubMed ID: 10385459
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate].
    Grandjean B; Guerci P; F Vial ; Raft J; Fuchs-Buder T; Bouaziz H
    Ann Fr Anesth Reanim; 2013 May; 32(5):378-9. PubMed ID: 23664923
    [No Abstract]   [Full Text] [Related]  

  • 8. Does the pretreatment of magnesium sulphate affect the sugammadex reversal time for rocuronium-induced neuromuscular blockade? A meta-analysis.
    Miao M; Zhang J
    J Clin Anesth; 2020 Mar; 60():78-79. PubMed ID: 31476625
    [No Abstract]   [Full Text] [Related]  

  • 9. Anaphylaxis incidence with rocuronium, succinylcholine, and atracurium: how risk communication can influence behavior.
    Dewachter P; Mouton-Faivre C
    Anesthesiology; 2015 Sep; 123(3):735-6. PubMed ID: 26284871
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative Neuromuscular Blockade Monitoring: Two Pictures of Unexpected Rocuronium Effect: A Case Report.
    Leonard PA; Todd MM
    A A Case Rep; 2017 Oct; 9(7):190-192. PubMed ID: 28542054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of subcutaneous infiltration of rocuronium: A case report.
    Timmermann TN; Mongan PD; Hoefnagel AL; Braunecker S
    J Clin Anesth; 2021 Aug; 71():110203. PubMed ID: 33609852
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
    Abad Gurumeta A; Gutiérrez García R
    Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaphylaxis to neuromuscular-blocking drugs: all neuromuscular-blocking drugs are not the same.
    Mertes PM; Volcheck GW
    Anesthesiology; 2015 Jan; 122(1):5-7. PubMed ID: 25383569
    [No Abstract]   [Full Text] [Related]  

  • 15. Pain on injection of rocuronium bromide.
    Joshi GP; Whitten CW
    Anesth Analg; 1997 Jan; 84(1):228. PubMed ID: 8989033
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-lasting potentiation of a single-dose of rocuronium by amikacin: case report.
    Gilliard V; Delvaux B; Russell K; Dubois PE
    Acta Anaesthesiol Belg; 2006; 57(2):157-9. PubMed ID: 16916186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No tolerance to rocuronium-induced neuromuscular blockade in a patient with prolonged testosterone therapy.
    Mizogami M; Mukozawa M; Kohno T; Takakura K
    J Clin Anesth; 2010 Nov; 22(7):579-80. PubMed ID: 21056825
    [No Abstract]   [Full Text] [Related]  

  • 18. The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios.
    Naguib M; Brewer L; LaPierre C; Kopman AF; Johnson KB
    Anesth Analg; 2016 Jul; 123(1):82-92. PubMed ID: 27140684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High need for sugammadex for rocuronium reversal with acute renal failure and normal need in the same patient with no renal impairment.
    Valente A
    J Clin Anesth; 2020 Dec; 67():109981. PubMed ID: 32682252
    [No Abstract]   [Full Text] [Related]  

  • 20. Accidental Ocular Rocuronium Exposure.
    Pierce AZ; Batra S; Norberg B
    Ann Emerg Med; 2021 Dec; 78(6):804-805. PubMed ID: 34802597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.